FGF21 and metabolic dysfunction-associated steatotic liver disease: Additionally, dysregulation of liver factors (primarily fetuin-A), fibroblast growth factor-21 (FGF-21), and selenoprotein P1 (SEPP1) contributes to the development of MASLD, alterations in lipid metabolism, and increased oxidative stress in women with PCOS.